EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    3.5.4.1 | Acquired Immunodeficiency Syndrome |
15452227 |
APOBEC3G genetic variants and their influence on the progression to AIDS. |
causal interaction
ongoing research
therapeutic application
unassigned |
2
2
1
0 |
| 3.5.4.1 | Acquired Immunodeficiency Syndrome |
15607551 |
A new approach to an AIDS vaccine: creating antibodies to HIV vif will enable apobec3G to turn HIV-infection into a benign problem. |
ongoing research
therapeutic application
unassigned |
1
2
0 |
| 3.5.4.1 | Acquired Immunodeficiency Syndrome |
16943852 |
Inhibition of HIV-1 replication by simian restriction factors, TRIM5alpha and APOBEC3G. |
ongoing research
therapeutic application
unassigned |
2
4
0 |
| 3.5.4.1 | Acquired Immunodeficiency Syndrome |
17374143 |
APOBEC3G levels predict rates of progression to AIDS. |
diagnostic usage
therapeutic application
unassigned |
4
1
0 |
| 3.5.4.1 | Acquired Immunodeficiency Syndrome |
20174454 |
Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS. |
causal interaction
unassigned |
2
0 |
| 3.5.4.1 | Acquired Immunodeficiency Syndrome |
21571098 |
Effect of HIV-1 Vif variability on progression to pediatric AIDS and its association with APOBEC3G and CUL5 polymorphisms. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
3
3
3 |
| 3.5.4.1 | Acquired Immunodeficiency Syndrome |
21955401 |
Increased APOBEC3G and APOBEC3F expression is associated with low viral load and prolonged survival in simian immunodeficiency virus infected rhesus monkeys. |
causal interaction
therapeutic application
unassigned |
4
1
0 |
| 3.5.4.1 | Acquired Immunodeficiency Syndrome |
22145963 |
APOBEC3-Mediated Editing in HIV Type 1 from Pediatric Patients and Its Association with APOBEC3G/CUL5 Polymorphisms and Vif Variability. |
diagnostic usage
ongoing research
unassigned |
1
1
0 |
| 3.5.4.1 | Acquired Immunodeficiency Syndrome |
22190037 |
Vif hijacks CBF-? to degrade APOBEC3G and promote HIV-1 infection. |
ongoing research
therapeutic application
unassigned |
2
1
0 |
| 3.5.4.1 | Acquired Immunodeficiency Syndrome |
24098115 |
APOBEC3G Polymorphism as a Selective Barrier to Cross-Species Transmission and Emergence of Pathogenic SIV and AIDS in a Primate Host. |
causal interaction
therapeutic application
unassigned |
2
1
0 |
